The therapeutic landscape for polymyalgia rheumatica (PMR) has grown and will grow further, allowing prolonged use of glucocorticoids (GCs) to be minimized, Anisha B. Dua, MD, MPH, of Feinberg School ...
In patients with polymyalgia rheumatica (PMR) who started glucocorticoids, the use of bisphosphonates was linked to a modest reduction in the risk for fragility fractures, whereas the use of proton ...
Polymyalgia rheumatica is an inflammatory condition that affects persons older than 50 years of age and is characterized by pain in both shoulders with or without hip or neck pain (or both) and with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results